Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of neural transmission. Supplementum

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-3-7091-9324-2_25PMID 7931226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+

  2005cited by this paper
• Cognitive effects of l-deprenyl in Alzheimer's disease

  2004cited by this paper
• Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.

  1993cited by this paper
• Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.

  1993cited by this paper
• Hydroxyl Free Radical (·OH) Formation Reflected by Salicylate Hydroxylation and Neuromelanin

  1993cited by this paper
• Complex mode of action of deprenyl in protection against MPTP-Parkinsonism in mice

  1992cited by this paper
• Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+.

  1992cited by this paper
• Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement

  1992cited by this paper
• Deprenyl reduces the death of motoneurons caused by axotomy

  1992cited by this paper
• Structure, expression, and function of, Ng‐CAM a member of the immunoglobulin superfamily involved in neuron‐neuron and neuron‐glia adhesion

  1992cited by this paper
• Enhanced hydroxyl radical generation by 2′‐methyl analog of MPTP: Suppression by clorgyline and deprenyl

  1992cited by this paper
• Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease

  1991cited by this paper
• Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

  1991cited by this paper
• Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease

  1991cited by this paper
• In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age

  1990cited by this paper
• Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

  1989cited by this paper
• The pharmacology of selegiline ((−)deprenyl). New aspects

  1989cited by this paper
• The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra

  1989cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper
• Effect of deprenyl on the progression of disability in early Parkinson's disease.

  1989cited by this paper
• Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

  1989cited by this paper
• Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

  1989cited by this paper
• Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1988cited by this paper
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

  1988cited by this paper
• Dopamine in the Extrapyramidal Motor Function A Study Based upon the MPTP‐Induced Primate Model of Parkinsonism” a

  1988cited by this paper
• The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals.

  1985cited by this paper
• Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study

  1985cited by this paper
• Deprenyl Protects Dopamine Neurons from the Neurotoxic Effect of 1‐Methyl‐4‐Phenylpyridinium Ion

  1985cited by this paper
• Catecholamine toxicity : a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease

  1984cited by this paper
• Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease.

  1984cited by this paper
• Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

  1984cited by this paper
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

  1984cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity.

  1981cited by this paper
• Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.

  1978cited by this paper

• Physicochemical characterization, antioxidant and hypoglycemic activities of selenized polysaccharides from Sargassum pallidum.

  2019cites this paper
• Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.

  2017cites this paper
• Effects of selenylation modification on structural and antioxidant properties of pectic polysaccharides extracted from Ulmus pumila L.

  2017cites this paper
• Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy

  2014cites this paper
• Selective serotonin reuptake inhibitors and tricyclic antidepressants : novel immunomodulating agents

  2012cites this paper
• MAO-B inhibitors protect against lipopolysaccharide-mediated epithelial barrier loss and cytokine release

  2011influential citation
• METALLOTHIONEINS AS EARLY AND SENSITIVE BIOMARKERS OF REDOX SIGNALING IN NEURODEGENERATIVE DISORDERS

  2011cites this paper
• L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation.

  2010cites this paper
• Antioxidant properties of PF9601N, a novel MAO-B inhibitor: assessment of its ability to interact with reactive nitrogen species.

  2010cites this paper
• ASSESSMENT OF SIMULTANEOUS INJECTION OF NEURAL STEM CELLS AND (-)-DEPRENYL TO IMPROVE CONTUSIVE SPINAL CORD INJURY IN RATS

  2010cites this paper
• Archive of SID Assessment of Simultaneous Injection of Neural Stem Cells and (-)-Deprenyl to Improve Contusive Spinal Cord Injury in Rats

  2010cites this paper
• Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals

  2009cites this paper
• Melatonin inhibits 6‐hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

  2009cites this paper
• Neuroprotective effect of catalpol against MPP(+)-induced oxidative stress in mesencephalic neurons.

  2007cites this paper
• Nitric oxide and MPP+-induced hydroxyl radical generation

  2006influential citation
• Acetylsalicylic acid and acetaminophen protect against MPP+-induced mitochondrial damage and superoxide anion generation.

  2006cites this paper
• Imidaprilat suppresses nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum.

  2006cites this paper
• L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.

  2006cites this paper
• Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity

  2005cites this paper
• Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.

  2004cites this paper
• Monoamine oxidase inhibitors, their structural analogues, and neuroprotection.

  2004cites this paper
• Pharmacological aspects of (-)-deprenyl.

  2004cites this paper
• Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson’s disease

  2004cites this paper
• (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.

  2004cites this paper
• Monoamine oxidase inhibitors

  2004cites this paper
• Antioxidant properties of newly synthesized N-propargylamine derivatives of nitroxyl: a comparison with deprenyl.

  2003cites this paper
• Slowing Parkinson’s disease progression

  2003cites this paper
• Protective effect of N‐(2‐propynyl)‐2‐(5‐benzyloxy‐indolyl) methylamine (PF 9601N), a novel MAO‐B inhibitor, on dopamine‐lesioned PC12 cultured cells

  2003cites this paper
• Neuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine

  2003cites this paper
• Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity

  2003cites this paper
• Dopamine efflux by MPTP and hydroxyl radical generation

  2002cites this paper
• Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+.

  2002cites this paper
• Melatonin attenuates MPP+‐induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway

  2002cites this paper
• Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo.

  2001cites this paper
• Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice.

  2001cites this paper
• Anti-apoptotic actions of R-2HMP in cerebellar granule cells : changes of mitochondrial membrane potential and sub-cellular GAPDH protein

  2001cites this paper
• Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors

  2001cites this paper
• Comparative effects of melatonin, l‐deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro

  2000cites this paper
• Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum

  1999cites this paper
• Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss.

  1999cites this paper
• Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate.

  1999cites this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

  1998cites this paper
• Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.

  1998cites this paper
• (-)-Deprenyl attenuates spinal motor neuron degeneration and associated locomotor deficits in rats subjected to spinal cord ischemia.

  1998cites this paper
• Melatonin prevents apoptosis induced by 6‐hydroxydopamine in neuronal cells: Implications for Parkinson's disease

  1998cites this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

  1998cites this paper
• The neuroprotective and neuronal rescue effects of (—)-deprenyl

  1998cites this paper
• Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease.

  1998cites this paper
• Aliphatic N-Methylpropargylamines as Potential Neurorescue Agents

  1998cites this paper
• Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid

  1997cites this paper
• In Vitro Induction of Apoptosis or Differentiation by Dopamine in an Immortalized Olfactory Neuronal Cell Line

  1997cites this paper
• Neuroprotection by the metabolic antioxidant alpha-lipoic acid.

  1997cites this paper
• Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress.

  1997cites this paper
• Pharmacology of selegiline

  1996cites this paper
• (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.

  1996cites this paper
• Deprenyl — Past and Future

  1996cites this paper
• In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates.

  1996cites this paper
• Modulation of gene expression rather than monoamine oxidase inhibition

  1996cites this paper
• Inhibition of lipid peroxidation attenuates axotomy‐induced apoptotic degeneration of facial motor neurons in neonatal rats

  1996cites this paper
• Novel sites of action for deprenyl in MPTP-parkinsonism: metabolite-mediated protection against striatal neurotoxicity and suppression of MPTP-induced increase of dopamine turnover in C57BL mice.

  1995cites this paper
• Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties.

  1995cites this paper
• Antioxidant Mechanism and Protection of Nigral Neurons Against MPP+ Toxicity by Deprenyl (Selegiline)

  1994cites this paper
• In Vivo Generation of Hydroxyl Radicals and MPTP‐Induced Dopaminergic Toxicity in the Basal Ganglia

  1994cites this paper
• What is it that l‐deprenyl (selegiline) might do? *

  1994cites this paper
• The Anticonvulsant FCE 26743 is a Selective and Short‐acting MAO‐B Inhibitor Devoid of Inducing Properties towards Cytochrome P450‐dependent Testosterone Hydroxylation in Mice and Rats

  1994cites this paper
• Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.

  1993cites this paper
• Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds

  1993cites this paper